A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formationJohn T. Brandt, Kenneth J. Winters, Govinda Weerakkody et al.|American Heart Journal|2006Cited by 571
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery diseaseTomas Jernberg, Lars Wallentin, Agneta Siegbahn et al.|European Heart Journal|2006Cited by 537
Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics DifferentlyNazar Farid, Daniel E. Salazar, Christelle Darstein et al.|Clinical Pharmacology & Therapeutics|2007Cited by 323
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose ClopidogrelChristopher D. Payne, Kenneth J. Winters, David S. Small et al.|Journal of Cardiovascular Pharmacology|2007Cited by 167
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationChristopher D. Payne, Joseph A. Jakubowski, Ying G. Li et al.|Thrombosis and Haemostasis|2008Cited by 120